Express News | HC Wainwright & Co. Reiterates Neutral on RAPT Therapeutics
H.C. Wainwright Maintains RAPT Therapeutics(RAPT.US) With Hold Rating
RAPT Therapeutics (RAPT) Gets a Hold From H.C. Wainwright
Express News | Rapt Therapeutics Will Reduce Its Workforce By 47 People, Or Approximately 40% Of Its Existing Headcount, The Company Estimates That It Will Incur Approximately $0.9M In Restructuring Charges-8K
Express News | RAPT Therapeutics - Will Incur About $0.9 Mln in Restructuring Charges in Connection With Workforce Reduction
Express News | RAPT Therapeutics Inc: Will Reduce Its Workforce by 47 People, or Approximately 40% of Company's Existing Headcount
Express News | RAPT Therapeutics Inc: Approved a Reduction of Company's Workforce to Conserve Cash Resources
Should You Sell Your Stake in RAPT Therapeutics (RAPT)?
Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround
12 Health Care Stocks Moving In Monday's After-Market Session
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Wolfe Downgrades RAPT, but Still Sees "Immense" Upside Potential
Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform
Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)
Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview
RAPT Falls for Second Day as Guggenheim, Barclays Downgrade Stock
Maintaining Hold Rating on RAPT Therapeutics Amid Clinical Uncertainties and Financial Outlook
Express News | RAPT Therapeutics Inc : Guggenheim Cuts to Neutral Rating
Express News | Guggenheim Downgrades RAPT Therapeutics to Neutral